Christof Scheid Selected Research

Therapeutic Uses

1/2020

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christof Scheid Research Topics

Disease

29	Multiple Myeloma 06/2022 - 02/2006
16	Neoplasms (Cancer) 01/2022 - 10/2002
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2004
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 12/2009
10	Lymphoma (Lymphomas) 01/2020 - 02/2011
9	Infections 10/2021 - 02/2011
9	Leukemia 01/2021 - 03/2004
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 12/2002
4	Disease Progression 01/2020 - 03/2004
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 10/2010
3	Bronchiolitis Obliterans Syndrome 12/2022 - 01/2019
3	Viremia 01/2020 - 08/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 10/2010
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 02/2013
3	Neutropenia 02/2015 - 03/2004
2	Inflammation (Inflammations) 04/2021 - 01/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 04/2018
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 01/2012
2	Hematologic Diseases (Blood Diseases) 10/2017 - 12/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2016 - 07/2015
2	Autoimmune Diseases (Autoimmune Disease) 11/2014 - 10/2002
2	Infarction (Infarctions) 05/2012 - 07/2006
2	Fever (Fevers) 02/2012 - 03/2004
2	Thrombotic Thrombocytopenic Purpura 10/2010 - 10/2002
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Anemia 04/2021
1	Primary Myelofibrosis (Myelosclerosis) 04/2021
1	Mycoses (Diseases, Fungus) 04/2021
1	Splenomegaly 04/2021
1	Bites and Stings (Sting) 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020
1	Polyneuropathies (Polyneuropathy) 11/2019

Drug/Important Bio-Agent (IBA)

9	Bortezomib (Velcade)FDA Link 10/2021 - 01/2012
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2012
6	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019 - 06/2012
5	Busulfan (Busulfex)FDA Link 01/2022 - 01/2016
5	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2016
5	Lenalidomide (CC 5013)FDA Link 01/2022 - 04/2016
4	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
4	treosulfanIBA 01/2022 - 01/2012
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2006
4	fludarabineIBA 01/2020 - 01/2016
3	Monoclonal AntibodiesIBA 01/2022 - 10/2002
3	Rituximab (Mabthera)FDA Link 01/2020 - 10/2002
3	Thalidomide (Thalomid)FDA Link 11/2019 - 01/2008
3	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 10/2010
3	Brentuximab VedotinIBA 01/2019 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 08/2017
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 07/2013
2	ibrutinibIBA 01/2020 - 01/2019
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 01/2018
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2013 - 09/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2012 - 02/2011
2	thiamine triphosphorate (TTP)IBA 10/2010 - 10/2002
1	Immunomodulating AgentsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 10/2021
1	Cidofovir (Vistide)FDA Link 10/2021
1	Voriconazole (Vfend)FDA LinkGeneric 10/2021
1	liposomal amphotericin B FDA Link 10/2021
1	posaconazole FDA Link 10/2021
1	Immunoglobulin M (IgM)IBA 10/2021
1	Immunoglobulin D (IgD)IBA 10/2021
1	IronIBA 04/2021
1	Hemoglobins (Hemoglobin)IBA 04/2021
1	Danazol (Azol)FDA LinkGeneric 04/2021
1	Janus Kinase InhibitorsIBA 04/2021
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2021
1	Everolimus FDA Link 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 01/2020
1	AntibodiesIBA 01/2020
1	Broadly Neutralizing AntibodiesIBA 01/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	plerixafor FDA Link 01/2020
1	Thymidine Monophosphate (TMP)IBA 11/2019
1	Prednisone (Sone)FDA LinkGeneric 11/2019

Therapy/Procedure

32	Stem Cell Transplantation 06/2022 - 10/2010
21	Therapeutics 01/2022 - 12/2002
17	Hematopoietic Stem Cell Transplantation 01/2019 - 12/2009
9	Cell Transplantation 12/2022 - 10/2017
9	Transplantation 01/2020 - 12/2009
7	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
3	Autologous Transplantation 01/2018 - 01/2016
3	Homologous Transplantation 07/2017 - 04/2013
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 03/2004
2	Salvage Therapy 01/2022 - 01/2020
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2014 - 02/2012
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2012 - 07/2006
2	Injections 05/2012 - 07/2006
2	Plasma Exchange 10/2010 - 10/2002
1	Immunotherapy 06/2022
1	Duration of Therapy 11/2019